A longitudinal quantitative EEG study of Alzheimer's disease: Relation to apolipoprotein E polymorphism

Dementia and Geriatric Cognitive Disorders

Volumn 11, Issue 1, 2000, Pages 29-35

  Lehtovirta, Maarit ^a   Partanen, Juhani ^b   Könönen, Mervi ^b   Hiltunen, Jaana ^b   Helisalmi, Seppo ^b   Hartikainen, Päivi ^b   Riekkinen Sr , Paavo ^b   Soininen, Hilkka ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

Alzheimer's disease; Apolipoprotein E; Cholinergic function; Quantitative EEG

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; FEMALE; FOLLOW UP; HUMAN; MALE; ONSET AGE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SLOW BRAIN WAVE;

EID: 0033959617     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017210     Document Type: Article

References (49)

1. Mayeux R, Stern Y, Spanton S: Heterogeneity in dementia of the Alzheimer type: Evidence of subgroups. Neurology 1985;35:453-461.
2. Rossor M, Iversen L, Reynolds G: Neurochemical characteristics of early and late onset types of Alzheimer's disease. BMJ 1984;288:961-964.
3. Rossor M: Molecular pathology of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1993; 56:583-586.
4. Sandbrink R, Hartmann T, Masters CL, Beyreuther K: Genes contributing to Alzheimer's disease. Mol Psychol 1996;1:27-40.
5. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
6. Lehtovirta M, Helisalmi S, Mannermaa A, Soinincn H, Koivisto K, Ryynänen M, Riekkinen P Sr: Apolipoprotein E polymorphism and Alzheimer's disease in Eastern Finland. Neurosci Lett 1995;185:13-15.
7. Mayeux R, Stern Y, Ottman R, Tatemichi TK, Tang M-X, Maestre G, Ngai C, Tycko B, Ginsberg H: The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol 1993;34: 752-754.
8. Saunders A, Strittmatter W, Schmechel D, St. George-Hyslop P, Pericak-Vance M, Joo S, Rosi B, Gusella J, Crapper-MacLachlan D, Alberts M, Hulette C, Crain B, Goldgraber D, Roses A: Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
9. Poirier J: Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994;17:525-530.
10. Soininen H, Kosunen O, Helisalmi S, Mannermaa A, Paljärvi L, Talasniemi S, Ryynänen M, Riekkinen Sr P: A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein ε4 allele. Neurosci Lett 1995;187:79-82.
11. Duffy FH, Albert MS, McAnulty G: Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type. Ann Neurol 1984;16:439-448.
12. Robinson DJ, Merskey H, Blume WT, Fry R, Williamson PC, Hachinski VC: Electroencephalography as an aid in the exclusion of Alzheimer's disease. Arch Neurol 1994;51:280-284.
13. Soininen H, Partanen J, Laulumaa V, Helkala E-L, Laakso M, Riekkinen PJ: Longitudinal EEG spectral analysis in early stage of Alzheimer's disease. Electroencephalogr Clin Neurophysiol 1989;72:290-297.
14. Coben LA, Danziger W, Storandt M: A longitudinal EEG study of mild senile dementia of Alzheimer type: Changes at 1 year and at 2.5 years. Electroencephalogr Clin Neurophysiol 1985;61:101-112.
15. Förstl H, Sattel H, Besthorn C, Daniel S, Geiger-Kabisch C, Hentschel F, Sarochan M, Zerfass R: Longitudinal cognitive, electroencephalographic and morphological brain changes in ageing and Alzheimer's disease. Br J Psychiatry 1996;168:280-286.
16. Rae-Grant A, Blume W, Lau C, Hachinski VC, Merskey H: The electroencephalogram in Alzheimer type dementia. Arch Neurol 1987;44: 50-54.
17. Sloan EP, Fenton GW: EEG power spectra and cognitive change in geriatric psychiatry: A longitudinal study. Electroencephalogr Clin Neurophysiol 1993;86:361-367.
18. Soininen H, Partanen J, Laulumaa V, Pääkkönen A, Helkala E-L, Riekkinen PJ: Serial EEG in Alzheimer's disease: 3 year follow-up and clinical outcome. Electroencephalogr Clin Neurophysiol 1991;79:342-348.
19. Riekkinen P, Buzsaki G, Riekkinen P Jr, Soininen H, Partanen J: The cholinergic system and EEG slow waves. Electroencephalogr Clin Neurophysiol 1991;78:89-96.
20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
21. Folstein MF, Folstein SE, McHugh PR: 'Mini-Mental State': A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189-198.
22. Reisberg B, Schneck MK, Ferris SH: The brief cognitive rating scale (BCRS): Findings in primary degenerative dementia (PDD). Psychopharmacol Bull 1983;19:734-739.
23. Webster DD: Clinical analysis of the disability on Parkinson's disease. Mod Treat 1968;5: 257-262.
24. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
25. Rosen WG, Terry RD, Fuld PA, Katzman R, Beck A: Pathological verification of ischaemic score in differentiation of dementias. Ann Neurol 1980;7:486-488.
26. Helkala EL, Hänninen T, Hallikainen M, Könönen M, Laakso MP, Hartikainen P, Soininen H, Partanen J, Partanen K, Vainio P, Riekkinen P Sr: Slow-wave activity in the spectral analysis of the electroencephalogram and volumes in hippocampus in subgroups of Alzheimer's disease patients. Behav Neurosci 1996;110:1235-1243.
27. Hartikainen P, Soininen H, Partanen J, Helkala E-L, Riekkinen P Sr: Aging and spectral analysis of EEG in normal subjects: A link to memory and CSF AChE. Acta Neurol Scand 1992;86:148-155.
28. Penttilä M, Partanen J, Soininen H, Riekkinen PJ: Quantitative analysis of occipital EEG in different stages of Alzheimer's disease. Electroencephalogr Clin Neurophysiol 1985;60: 1-6.
29. Gasser T, Bächer P, Möcks J: Transformation towards the normal distribution of broad band spectral parameters of the EEG. Electroencephalogr Clin Neurophysiol 1982;53:119-124.
30. Hixon JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31: 545-548.
31. Tsukamoto K, Watanabe T, Matsushima T, Kinoshita M, Kato H, Hashimoto Y, Kurokawa K, Teramoto T: Determination by PCR-RFLP of apoE genotype in a Japanese population. J Lab Clin Med 1993;121:598-602.
32. Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT: Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 1996;47:444-448.
33. Holmes C, Levy R, McLoughlin DM, Powell JF, Lovestone S: Apolipoprotein E: Non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996;61:580-583.
34. Kurz A, Egensperger R, Haupt M, Lautenschlager N, Romero B, Graeber MB, Müller U: Apolipoprotein E ε4 allele cognitive decline and deterioration of everyday performance in Alzheimer's disease. Neurology 1996;47:440-443.
35. Schreiter-Gasser U, Gasser T, Ziegler P: Quantitative EEG analysis in early onset Alzheimer's disease: Correlations with severity clinical characteristics visual EEG and CCT. Electroencephalogr Clin Neurophysiol 1994;90: 267-272.
36. Jelic V, Julin P, Shigeta M, Nordberg A, Lannfelt L, Winblad B, Wahlund L-O: Apolipoprotein E ε4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence. J Neurol Neurosurg Psychiatry 1997;63:59-65.
37. Perry EK: The cholinergic hypothesis - Ten years on. Br Med Bull 1986;42:63-69.
38. Whitehouse P, Price DL, Struble RG, Clark AW, Coyle JT, De Long RM: Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 1982;215:1237-1239.
39. Riekkinen P Jr, Sirviö J, Riekkinen PJ: Relationship between the cortical choline acetyltransferase content and EEG delta power. J Neurosci Res 1990;8:12-20.
40. Soininen H, Reinikainen KJ, Partanen J, Helkala E-L, Paljärvi L, Riekkinen PJ: Slowing of electroencephalogram and choline acetyltransferase activity in post mortem frontal cortex in definite Alzheimer's disease. Neuroscience 1992;49:529-535.
41. Wurtman RJ: Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci 1992;15:117-122.
42. Svensson AL, Warpman U, Hellstrom-Lindahl E, Bogdanovic N, Lannfelt L, Nordberg A: Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes. Neurosci Lett 1997;232:37-40.
43. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K: Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jacob disease. Brain Res 1991;541:163-166.
44. Wisniewski T, Frangione B: Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992;135:235-238.
45. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance MA, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90:1977-1981.
46. Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong LM, Jakes R, Alberts MJ, Gilbert JR, Han S-H, Hulette C, Einstein G, Schmechel DE, Pericak-Vance MA, Roses AD: Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994;125:163-171.
47. Rebeck GW, Reiter JS, Strickland DK, Hyman BT: Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 1993;11:575-580.
48. Schmechel DE, Saunders AM, Strittmatter WJ, Crain B, Hulette C, Joo SH, Pericak-Vance MA, Goldgraber D, Roses AD: Increased amyloid β-peptide deposition as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:9649-9653.
49. Chapman S, Michaelson DM: Specific neurochemical derangements of brain projecting neurons in apolipoprotein E-deficient mice. J Neurochem 1998;70:708-714.